VTR - Ventas Inc Stock Analysis
Ventas Inc (VTR) is a publicly traded company listed on the NYSE. It operates in the REIT - Healthcare Facilities industry, part of the broader Real Estate sector. The company has a market capitalization of 41.68B, generates annual revenue of 5.83B, and reports net income of 251.38M. As of the latest data, the stock is trading at 85.69 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock is trading at a high valuation compared to the market average, suggesting investor optimism or growth expectations. The PEG ratio is above 2, which could imply the stock is overvalued based on its growth outlook. The company uses a significant amount of debt to finance its operations, which can boost returns but adds financial risk. The stock offers a moderate dividend yield (2.39%), which may appeal to income-focused investors. This stock tends to be less volatile than the overall market, often preferred by conservative investors.
Analyst recommendation stands at Buy (4.12), indicating current market sentiment. Institutional ownership is reported at 99.72%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of 43.85%, trading within a 52-week range of 58.72 - 84.10.
VTR - Ventas Inc
85.69
Analyst Consensus
Buy 4.12
VTR – Analyst Rating Summary
- Strong Buy: 7
- Buy: 14
- Hold: 4
- Sell: 0
- Strong Sell: 0
- Total Analysts: 25
| Index: | S&P 500 | P/E: | 158.04 | EPS (ttm): | 0.54 | Insider Own: | 0.49% | Shs Outstand: | 474.93M | Perf Week: | 10.24% |
| Market Cap: | 41.68B | Forward P/E: | 82.36 | EPS next Y: | 1.04 | Insider Trans: | -24.42% | Shs Float: | 472.62M | Perf Month: | 13.23% |
| Income(ttm): | 251.38M | PEG: | 2.08 | EPS next Q: | 0.11 | Inst Own: | 99.72% | Short Float: | 3.06% | Perf Quarter: | 12.79% |
| Revenue(ttm): | 5.83B | P/S: | 7.14 | EPS this Y: | 33.74% | Inst Trans: | 2.50% | Short Ratio: | 4.86 | Perf Half Y: | 25.08% |
| Book/sh: | 26.38 | P/B: | 3.25 | EPS next Y: | 44.06% | ROA: | 0.93% | Short Interest: | 14.45M | Perf Year: | 43.85% |
| Cash/sh: | 1.62 | P/C: | 53.01 | EPS next 5Y: | 39.68% | ROE: | 2.16% | 52W Range: | 58.72 - 84.10 | Perf YTD: | 10.74% |
| Dividend Est.: | 2.05 (2.39%) | P/FCF: | 31.66 | EPS past 3/5Y: | - -14.17% | ROIC: | 1.06% | 52W High: | 84.10 1.90% | Beta: | 0.77 |
| Dividend TTM: | 1.92 (2.24%) | Quick Ratio: | 0.51 | Sales past 3/5Y: | 12.23% 8.99% | Gross Margin: | 19.39% | 52W Low: | 58.72 45.93% | Perf 5Y: | 72.17% |
| Dividend Ex-Date: | Mar 31, 2026 | Current Ratio: | 0.51 | EPS Y/Y TTM: | 185.15% | Oper. Margin: | 15.82% | RSI (14): | 80.61 | Volatility: | 2.69% 2.14% |
| Employees: | 542 | Debt/Eq: | 1.06 | Sales Y/Y TTM: | 18.47% | Profit Margin: | 4.31% | Recom: | 1.45 | Target Price: | 89.53 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.89 | EPS Q/Q: | 9.86% | Payout: | 353.33% | Rel Volume: | 1.34 | Prev Close: | 83.90 |
| Sales Surprise: | 4.09% | EPS Surprise: | 48.96% | Sales Q/Q: | 21.67% | Earnings: | Feb 05 AMC | Avg Volume: | 2.97M | Price: | 85.69 |
| SMA20: | 9.02% | SMA50: | 9.19% | SMA200: | 21.15% | Overbought: -4.48% | Volume: | 3,986,457 | Change: | 2.13% | |
Graham Classic formula value: 42.6
(P/E=8 * 1g) Min value: 23.12
(current P/E * 2g) Max value: 115.11
Average value: 60.28
About Ventas Inc
Ventas, Inc. engages in the acquisition and ownership of seniors housing and healthcare properties. It operates through the following segments: Senior Housing Operating Portfolio (SHOP), Outpatient Medical and Research Portfolio (OM&R), and Triple-net Leased Properties (NNN). The SHOP segment is involved in owning and investing in senior housing communities throughout the United States and Canada. The OM&R segment refers to acquiring, owning, development, leasing and managing outpatient medical buildings and research centers throughout the United States. The NNN segment focuses on investing and owning senior housing communities, skilled nursing facilities, long-term acute care facilities, freestanding inpatient rehabilitation facilities, and other healthcare facilities throughout the United States and the United Kingdom. The company was founded in 1983 and is headquartered in Chicago, IL.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.